Hybridoma in Biological Technology

InVitria Reveals Technology to Optimize Hybridoma Production Performance

... media and the leading commercial serum-free hybridoma media formulations proved that InVitria’s ... optimized cell growth and productivity of hybridoma cells. 1 Further, the studies revealed that ... media. We also reported that Lacromin improves hybridoma cell culture performance.” Lacromin ...

InVitria's Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin

... many cell lines, including Chinese Hamster Ovary (CHO) cells and Mouse hybridoma cells. -- Outperforms Transferrin Lacromin(TM) promotes higher cell ... or prion contaminant risks. -- Improves IgG Productivity In hybridoma cells, Lacromin(TM) increased IgG productivity by 50% versus ...

Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences

... Biosciences, Inc. is a contract research and development organization in Morgan Hill, California. Aragen specializes in recombinant cell line and hybridoma development, cell culture and purification process development and production, cell-based assays and custom immunological services. ( ...

InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication

... InVitria's recombinant albumin (Cellastim™) outperforms plasma-derived human serum albumin and results in productivity improvements in CHO and hybridoma cell lines. InVitria's recombinant lactoferrin (Lacromin™) is a strong cell growth factor and is capable of performing better in cell ...

New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture

... ) is a strong growth factor for promoting cell growth and cell productivity across a variety of cell lines, including intestinal cells, hybridoma cells, osteoblast cells and embryonic kidney (293) cells. A global collaborative research effort led to the findings. The study included research ...

Abeome Forms First Class Scientific Advisory Board

... scientists to insure Abeome's future success." About Abeome Abeome Corporation is a biotechnology company dedicated to leveraging its proprietary hybridoma technology to accelerate and improve the development of monoclonal antibodies for life sciences. Abeome owns an exclusive license for the technology ...

Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results

... Biology Lab in Dallas and its facility in Newark, Delaware in response to growth in demand for both GAT and conventional hybridoma development. This follows the expansion of the Company's Windham, Maine antibody production facility during November 2007, which ...

A Mix-and-Read Cell-Based Assay for Hybridoma Screening Using the FMAT 8100 HTS System

... mix-and-read, cell-based assay for screening hybridoma supernatants using the fluorometric ... the surface antigen were incubated with 5 L of hybridoma supernatant and were ... more sensitive and reliable method for hybridoma screening. Introduction ...

Gram Quantities of MAb Produced with Simple Bioreactor in Serum-Free Perfusion Culture Replacing Ascitic Fluid Production

... when the top DO setpoint could not be maintained. Gibcos hybridoma Serum-Free Medium was used, supplemented with between 2 - 4 mM L-glutamine ... to maintain the residual glucose concentration at > 1 g/L. The hybridoma cell line used produces an IgG 1 MAb. Perfusion at 1 volume/ day (based ...

Hybridoma Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor

... (NBS Catalog # M1273-3202) was used for perfusion in order to grow the hybridoma cells in a continuous mode. Additionally, BioCommand Plus supervisory ... from Hyclone and 0.1% Pluronic from Gibco. Inoculum hybridoma cell line 3G5 from ATCC Inoculum was cultivated in an NBS ...

Biotech industry reaches midpoint in 50-year maturation cycle

... First Decade (late 1970s/early 1980s to late 1980s): Laying down the foundation research methodologies and how we study and view recombinant DNA and hybridoma technologies. Monoclonal antibodies were initially developed at this point but as diagnostic reagents. Hybritech in San Diego was a company ...

A technique for increasing yields in bioreactors and disposable cell-culture systems

... a packed bed bioreactor. Cytotechnology 33 , 311 (2000). 2. Wang, G. et al. Modified CelliGen-packed bed bioreactors for hybridoma cell cultures. Cytotechnology 9 , 4149 (1992). Rajul Vyas & Julia Cino New Brunswick Scientific, PO ...

Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System

... at : www.nbsc.com/btb.htm References: 1. Wang, G. et al. Modified CelliGen Packed-Bed Bioreactors for hybridoma Cell Culture. Cytotechnology 9:41-49, 1992. 2. Kaufman J.B., Wang, G., Zhang, L., Valle, M.A. and Shiloach, J. Continuous ...

Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells

... of saving time. As an example of the typical savings one could expect, a single 5-L bioreactor has been shown to produce the equivalent amount of hybridoma cells as 150 250-mL T-flasks 1 . Moreover, a bioreactor requires only one laboratory technician and less than 2 ft of bench space for operation. ...

Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies

... 0.1 g/ml of antibody in 5 minutes. For decades, antibodies have been used as key reagents for biological research. The development of hybridoma technology, which generates monoclonal antibodies, has resulted in the development of a significant number of immunoglobulins for research and ...